Robert M. DiPardo

Methods for drug discovery: development of potent, selective, orally effective cholecystokinin antagonists

B. Evans, Kenneth E. Rittle, Mark G. Bock et al. · Journal of Medicinal Chemistry · 1988 · 1.4K citations · Full text

Peptide Hormone Cholecystokinin, Medicinal Chemistry, Drug Target +15

Design of potent, orally effective, nonpeptidal antagonists of the peptide hormone cholecystokinin.

B. Evans, Mark G. Bock, Kenneth E. Rittle et al. · Proceedings of the National Academy of Sciences · 1986 · 327 citations · Full text

Peptide Engineering, Peptide Science, Pharmacotherapy +19

Benzodiazepine gastrin and brain cholecystokinin receptor ligands; L-365,260

Mark G. Bock, Robert M. DiPardo, B. Evans et al. · Journal of Medicinal Chemistry · 1989 · 309 citations · Full text

Altmetric Attention Score, Pharmacotherapy, Experimental Pharmacology +18

Tetrabutylammonium Salt Induced Denitration of Nitropyridines:  Synthesis of Fluoro-, Hydroxy-, and Methoxypyridines

Scott D. Kuduk, Robert M. DiPardo, Mark G. Bock · Organic Letters · 2005 · 87 citations

Chemical Engineering, Engineering, Efficient Method +8

Orally active, nonpeptide oxytocin antagonists

B. Evans, James L. Leighton, Kenneth E. Rittle et al. · Journal of Medicinal Chemistry · 1992 · 80 citations · Full text

Medicinal Chemistry, Anesthesia, Medicine +15